REstoration of VItamin D in Pulmonary Arterial Hypertension

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Pulmonary Artery HypertensionVitamin d Deficiency
Interventions
DRUG

Calcifediol Oral Capsule

One Hydroferol® soft capsule (0.266 mg) will be administered once weekly for the first 12 weeks and one capsule every two weeks for the next 12 weeks.

DRUG

Placebo

One soft capsule will be administered once weekly for the first 12 weeks and one capsule every two weeks for the next 12 weeks.

All Listed Sponsors
collaborator

Universidad Complutense de Madrid

OTHER

collaborator

Hospital Clinic of Barcelona

OTHER

collaborator

Hospital Vall d'Hebron

OTHER

collaborator

Hospital Universitario Marqués de Valdecilla

OTHER

collaborator

Hospital Universitario de Gran Canaria Doctor Negrín

UNKNOWN

collaborator

Hospital Universitario La Fe

OTHER

collaborator

Hospital Universitario Doctor Peset

OTHER

collaborator

Hospital Universitario Ramon y Cajal

OTHER

collaborator

Hospitales Universitarios Virgen del Rocío

OTHER

lead

Parc de Salut Mar

OTHER

NCT06258850 - REstoration of VItamin D in Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter